Akoya Biosciences Inc (AKYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
Sales | 16,158 | 13,476 | 13,071 | 12,212 | 12,908 |
Cost of Goods | 5,932 | 5,023 | 4,937 | 4,807 | 5,000 |
Gross Profit | 10,226 | 8,453 | 8,134 | 7,405 | 7,908 |
Operating Expenses | 27,938 | 19,215 | 15,449 | 13,613 | 11,057 |
Operating Income | -16,780 | -10,739 | -6,378 | -5,401 | -3,149 |
Interest Expense | 844 | 763 | 757 | 751 | 745 |
Other Income | -166 | -126 | 1,566 | -1,936 | -1,826 |
Pre-tax Income | -17,790 | -11,628 | -5,569 | -8,088 | -5,720 |
Income Tax | -117 | -11 | -6 | -6 | -26 |
Net Income Continuous | -17,673 | -11,617 | -5,563 | -8,082 | -5,694 |
Net Income | $-17,673 | $-11,617 | $-5,563 | $-8,082 | $-5,694 |
EPS Basic Total Ops | 2.40 | -0.31 | -0.20 | -3.54 | -2.50 |
EPS Basic Continuous Ops | 1.89 | -0.31 | -0.19 | -2.99 | -2.30 |
EPS Diluted Total Ops | 2.40 | -0.31 | -0.20 | -3.54 | -2.50 |
EPS Diluted Continuous Ops | 1.89 | -0.31 | -0.19 | -2.99 | -2.30 |
EBITDA(a) | $-15,406 | $-9,495 | $-5,245 | $-4,360 | $-2,126 |